|
|
|
Masoud Azodi, M.D., FACOG |
|
|
|
OBGYN
Assistant Professor, Gyn Oncology, Yale University School of Medicine
|
|
 |
|
|
|
|
|
|
| |
|
Education |
|
|
|
| Under Graduate: | | University of Akron |
| Medical School: | | Wright State University School of Medicine |
| Residency: | | Northeastern Ohio Universities College of Medicine |
| Fellowship: | | Yale University School of Medicine |
|
|
|
Faculty Appointments |
|
|
|
| Bridgeport Hospital, Chief of Gyn-Oncology |
| Yale School of Medicine, Associate Professor of Ob-Gyn |
|
|
|
Academic Activities |
|
|
|
DaVinci Robot-Difficult 9 hour surgery |
|
|
Publications |
|
|
|
Abidi A, Mann K, Sherman A, Konia T, Azodi M. Cervical carcinosarcoma: a case report. Journal of Medicine. 2008 Feb 15;14(4):1065-72.
Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-saaib R, Yu H, Azodi M, Rutherford T, Schwartz PE< Mor G. Diagnostic markers for early detection of overian cancer. Clin Cancer Res. 2008 Feb 15;14(4):1065-72.
Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-a2.1-positive healthy donors and patients with advanced ovarian cancer. American Journal of Ob/Gyn. 2009 Jan;200(1):75.el-10.
Bellone S, Anfossi S, O'Brian TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1- positive healthy donors and patients with advanced ovarian cancer. Cancer. 2009 Feb 15;115(4):800-11.
Toy EP, Azodi M, Folk NL, Zito CM, Ziess CJ, Chambers SK. Enhanced overian cancer tumorigenesis and metastasis by the colony-stimulating factor. Neoplasia. 2009 Feb:11(2):136-44.
Tan O, Luchansky E, Rosenman S, Pua T, Azodi M. Peritoneal tuberculosis with elevated serum CA125 level mimicking advanced stage overian cancer; a case report. Arch Ob/Gyn. 2009 Jan 31.
Bellone S, El-Sahwi K, Cocco E< Casagrande F, Cargnelutti M, Palmiere M, Bignotti E, Romani C, Silasi AD. (2008) HPV16 VLP L1-specific CD8+ cytotoxic T lymphocytes (CTL) are equally effective to E7-specific CD8+ CTL in killing autologous HPV16 positive tumor cells in cervical cancer patients: Implication for L1 dendretic cell based therapeutic vaccines. J Virol. 2009 Jul:83(13):6779-89. |
|
|
|
Return to List |
|
|
|
|
|
|
|